1H-pyrrolo[2,3-b]pyridine: A new scaffold for human neutrophil elastase (HNE) inhibitors

Letizia Crocetti, Maria Paola Giovannoni, Igor A. Schepetkin, Mark T. Quinn, Andrei I. Khlebnikov, Niccolò Cantini, Gabriella Guerrini, Antonella Iacovone, Elisabetta Teodori, Claudia Vergelli

Research output: Contribution to journalArticle

Abstract

Human neutrophil elastase (HNE) is a potent serine protease belonging to the chymotrypsin family. It is an important target for the development of novel and selective inhibitors for the treatment of inflammatory diseases, especially pulmonary pathologies. Here, we report the synthesis and biological evaluation of a new series of HNE inhibitors with a pyrrolo[2,3-b]pyridine scaffold, which is an isomer of our previously reported indazoles, in order to assess how a shift of the nitrogen from position 2 to position 7 influences activity. The majority of new compounds were effective HNE inhibitors and had IC50 values in the micromolar/submicromolar range, with some compounds active in low nanomolar levels. For example, 2a and 2b inhibited HNE with IC50 values of 15 and 14 nM, respectively. Molecular modeling of compounds differing in the position of heteroatom(s) in the bicyclic moiety and in the oxadiazole ring demonstrated that the calculated geometries of enzyme-inhibitor complexes were in agreement with the observed biological activities. Docking experiments showed that orientation of the active pyrrolo[2,3-b]pyridines in the HNE catalytic triad Ser195-His57-Asp102 correlated with effectiveness of the inhibitor interaction with the enzyme. Thus, the pyrrolo[2,3-b]pyridine scaffold represents a novel scaffold for the development of potent HNE inhibitors.

LanguageEnglish
Pages5583-5595
Number of pages13
JournalBioorganic and Medicinal Chemistry
Volume26
Issue number21
DOIs
Publication statusPublished - 15 Nov 2018

Fingerprint

Secretory Proteinase Inhibitory Proteins
Leukocyte Elastase
Scaffolds
Indazoles
Oxadiazoles
Pulmonary diseases
Molecular modeling
Inhibitory Concentration 50
Chymotrypsin
Serine Proteases
Enzyme Inhibitors
Pathology
Bioactivity
Isomers
Nitrogen
Human Development
Geometry
Lung Diseases
Enzymes
pyrrolo(2, 3-b)pyridine

Keywords

  • Human neutrophil elastase
  • Inhibitor
  • Molecular docking
  • Pyrrolo[2,3-b]pyridine

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Cite this

1H-pyrrolo[2,3-b]pyridine : A new scaffold for human neutrophil elastase (HNE) inhibitors. / Crocetti, Letizia; Giovannoni, Maria Paola; Schepetkin, Igor A.; Quinn, Mark T.; Khlebnikov, Andrei I.; Cantini, Niccolò; Guerrini, Gabriella; Iacovone, Antonella; Teodori, Elisabetta; Vergelli, Claudia.

In: Bioorganic and Medicinal Chemistry, Vol. 26, No. 21, 15.11.2018, p. 5583-5595.

Research output: Contribution to journalArticle

Crocetti, L, Giovannoni, MP, Schepetkin, IA, Quinn, MT, Khlebnikov, AI, Cantini, N, Guerrini, G, Iacovone, A, Teodori, E & Vergelli, C 2018, '1H-pyrrolo[2,3-b]pyridine: A new scaffold for human neutrophil elastase (HNE) inhibitors' Bioorganic and Medicinal Chemistry, vol. 26, no. 21, pp. 5583-5595. https://doi.org/10.1016/j.bmc.2018.09.034
Crocetti, Letizia ; Giovannoni, Maria Paola ; Schepetkin, Igor A. ; Quinn, Mark T. ; Khlebnikov, Andrei I. ; Cantini, Niccolò ; Guerrini, Gabriella ; Iacovone, Antonella ; Teodori, Elisabetta ; Vergelli, Claudia. / 1H-pyrrolo[2,3-b]pyridine : A new scaffold for human neutrophil elastase (HNE) inhibitors. In: Bioorganic and Medicinal Chemistry. 2018 ; Vol. 26, No. 21. pp. 5583-5595.
@article{296751f16d8b49ef99a160bcbc445c85,
title = "1H-pyrrolo[2,3-b]pyridine: A new scaffold for human neutrophil elastase (HNE) inhibitors",
abstract = "Human neutrophil elastase (HNE) is a potent serine protease belonging to the chymotrypsin family. It is an important target for the development of novel and selective inhibitors for the treatment of inflammatory diseases, especially pulmonary pathologies. Here, we report the synthesis and biological evaluation of a new series of HNE inhibitors with a pyrrolo[2,3-b]pyridine scaffold, which is an isomer of our previously reported indazoles, in order to assess how a shift of the nitrogen from position 2 to position 7 influences activity. The majority of new compounds were effective HNE inhibitors and had IC50 values in the micromolar/submicromolar range, with some compounds active in low nanomolar levels. For example, 2a and 2b inhibited HNE with IC50 values of 15 and 14 nM, respectively. Molecular modeling of compounds differing in the position of heteroatom(s) in the bicyclic moiety and in the oxadiazole ring demonstrated that the calculated geometries of enzyme-inhibitor complexes were in agreement with the observed biological activities. Docking experiments showed that orientation of the active pyrrolo[2,3-b]pyridines in the HNE catalytic triad Ser195-His57-Asp102 correlated with effectiveness of the inhibitor interaction with the enzyme. Thus, the pyrrolo[2,3-b]pyridine scaffold represents a novel scaffold for the development of potent HNE inhibitors.",
keywords = "Human neutrophil elastase, Inhibitor, Molecular docking, Pyrrolo[2,3-b]pyridine",
author = "Letizia Crocetti and Giovannoni, {Maria Paola} and Schepetkin, {Igor A.} and Quinn, {Mark T.} and Khlebnikov, {Andrei I.} and Niccol{\`o} Cantini and Gabriella Guerrini and Antonella Iacovone and Elisabetta Teodori and Claudia Vergelli",
year = "2018",
month = "11",
day = "15",
doi = "10.1016/j.bmc.2018.09.034",
language = "English",
volume = "26",
pages = "5583--5595",
journal = "Bioorganic and Medicinal Chemistry",
issn = "0968-0896",
publisher = "Elsevier Limited",
number = "21",

}

TY - JOUR

T1 - 1H-pyrrolo[2,3-b]pyridine

T2 - Bioorganic and Medicinal Chemistry

AU - Crocetti, Letizia

AU - Giovannoni, Maria Paola

AU - Schepetkin, Igor A.

AU - Quinn, Mark T.

AU - Khlebnikov, Andrei I.

AU - Cantini, Niccolò

AU - Guerrini, Gabriella

AU - Iacovone, Antonella

AU - Teodori, Elisabetta

AU - Vergelli, Claudia

PY - 2018/11/15

Y1 - 2018/11/15

N2 - Human neutrophil elastase (HNE) is a potent serine protease belonging to the chymotrypsin family. It is an important target for the development of novel and selective inhibitors for the treatment of inflammatory diseases, especially pulmonary pathologies. Here, we report the synthesis and biological evaluation of a new series of HNE inhibitors with a pyrrolo[2,3-b]pyridine scaffold, which is an isomer of our previously reported indazoles, in order to assess how a shift of the nitrogen from position 2 to position 7 influences activity. The majority of new compounds were effective HNE inhibitors and had IC50 values in the micromolar/submicromolar range, with some compounds active in low nanomolar levels. For example, 2a and 2b inhibited HNE with IC50 values of 15 and 14 nM, respectively. Molecular modeling of compounds differing in the position of heteroatom(s) in the bicyclic moiety and in the oxadiazole ring demonstrated that the calculated geometries of enzyme-inhibitor complexes were in agreement with the observed biological activities. Docking experiments showed that orientation of the active pyrrolo[2,3-b]pyridines in the HNE catalytic triad Ser195-His57-Asp102 correlated with effectiveness of the inhibitor interaction with the enzyme. Thus, the pyrrolo[2,3-b]pyridine scaffold represents a novel scaffold for the development of potent HNE inhibitors.

AB - Human neutrophil elastase (HNE) is a potent serine protease belonging to the chymotrypsin family. It is an important target for the development of novel and selective inhibitors for the treatment of inflammatory diseases, especially pulmonary pathologies. Here, we report the synthesis and biological evaluation of a new series of HNE inhibitors with a pyrrolo[2,3-b]pyridine scaffold, which is an isomer of our previously reported indazoles, in order to assess how a shift of the nitrogen from position 2 to position 7 influences activity. The majority of new compounds were effective HNE inhibitors and had IC50 values in the micromolar/submicromolar range, with some compounds active in low nanomolar levels. For example, 2a and 2b inhibited HNE with IC50 values of 15 and 14 nM, respectively. Molecular modeling of compounds differing in the position of heteroatom(s) in the bicyclic moiety and in the oxadiazole ring demonstrated that the calculated geometries of enzyme-inhibitor complexes were in agreement with the observed biological activities. Docking experiments showed that orientation of the active pyrrolo[2,3-b]pyridines in the HNE catalytic triad Ser195-His57-Asp102 correlated with effectiveness of the inhibitor interaction with the enzyme. Thus, the pyrrolo[2,3-b]pyridine scaffold represents a novel scaffold for the development of potent HNE inhibitors.

KW - Human neutrophil elastase

KW - Inhibitor

KW - Molecular docking

KW - Pyrrolo[2,3-b]pyridine

UR - http://www.scopus.com/inward/record.url?scp=85055558073&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055558073&partnerID=8YFLogxK

U2 - 10.1016/j.bmc.2018.09.034

DO - 10.1016/j.bmc.2018.09.034

M3 - Article

VL - 26

SP - 5583

EP - 5595

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

SN - 0968-0896

IS - 21

ER -